At a glance
ClinicalIndex Comparison RecordN/ACompleted· 217 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers
In Brief
An observational study for Stimulant Dependence. Completed, enrolled 217 participants across 6 sites.
Detailed Summary
The purpose of this study is to determine whether performance on neurocognitive measures predicts treatment outcomes in individuals with substance abuse disorders. A second purpose is to compare the risk of damage, as well as actual damage, to DNA and other cell parts in people with substance abuse disorders to that of people who do not have substance abuse disorders.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStimulant Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedMar 2008
Primary CompletionOct 2009
Study CompletionMar 2010
TodayJul 2026
First PostedMar 5, 2008
Enrollment StartFeb 1, 2008
Primary CompletionOct 1, 2009
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 18.3 years ago